What We Study
Population Bio’s Drug Development Research Programs
Drug safety, identify genetic variants that increase the risk of a serious adverse event (SAE) to pre-screen patients before taking the drug.
Drug repurposing, identify genetic subtypes of common diseases that can match patients to approved drugs as a new indication.
Drug rescue, identify genetic variants for responders in clinical trials (patient stratification) of novel therapies and enable drug approval.
Population Bio’s Disease Research Pipeline
Alzheimer’s Disease
Parkinson’s Disease
Autism Spectrum Disorder
Endometriosis
Progressive Multifocal Leukoencephalopathy